Related Experiment Videos
Estrogen improves abnormal norepinephrine-induced vasoconstriction in postmenopausal women
1Department of Medicine, State University of New York and Millard Fillmore Hospital, Buffalo 14209, USA. bsung@mfhs.edu
Journal of Hypertension
|July 15, 1999
Summary
Postmenopausal women exhibit heightened blood pressure responses to mental stress due to increased vasoconstriction and reduced estrogen-mediated vasodilation. Estrogen replacement therapy can mitigate these effects.
Area of Science:
- Cardiovascular Physiology
- Endocrinology
- Women's Health
Background:
- Postmenopausal women may experience exaggerated blood pressure responses to mental stress.
- The precise mechanisms underlying this phenomenon remain unclear.
- Estrogen's role in modulating vascular responses to stress is an area of active investigation.
Purpose of the Study:
- To investigate the role of estrogen in the blood pressure response to mental stress in postmenopausal women.
- To compare hemodynamic and vascular responses to stress and norepinephrine across different menopausal and hormonal status groups.
Main Methods:
- Hemodynamic responses to mental stress and norepinephrine-induced vasoconstriction were assessed in premenopausal women, postmenopausal women, and postmenopausal women on estrogen replacement therapy.
- Norepinephrine infusion and mental arithmetic tests were employed.
- Venous diameter changes were measured using ultrasonography.
Main Results:
- Postmenopausal women demonstrated a significantly greater blood pressure response to mental stress compared to premenopausal women or those on estrogen therapy (P < 0.01).
- Postmenopausal women exhibited significantly greater norepinephrine-induced vasoconstriction than the other groups (P = 0.02).
- Estrogen replacement therapy (Premarin) significantly attenuated norepinephrine-induced vasoconstriction in postmenopausal women (P < 0.001).
Conclusions:
- Healthy, normotensive postmenopausal women show an exaggerated blood pressure response to mental stress.
- Increased vasoconstriction to norepinephrine and diminished estrogen-mediated vasodilation likely contribute to heightened stress-induced blood pressure increases in postmenopausal women lacking estrogen replacement therapy.